301281.SZ · 科源制药
China A-shares · RS rating 63 · As of 2026-10-14
| Price | 42.64 CNY |
|---|---|
| 1-day change | -3.9% |
| RS rating (overall / 1M / 3M / 12M) | 63 / 21 / 24 / 86 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 35 / 30 / 14 |
| Industry group (rank) | Medical-Products (64) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +5.5% |
| Distance from 52-week high | +26.6% |
| Market cap (USD) | $744.6M |